Abstract:The easy tunable photophysical properties of Ru(II) polypyridyl complexes, together with their water solubility, photochemical stability and high biocompatibility make them suitable as agents for photodynamic therapy (PDT). The development of complexes containing new ligands is a step forward in the improvement and application of these compounds as photosensitizer and photocytotoxic agents. We report the synthesis of a set of Ru(II)-polypyridyl complexes with different electronic properties and delocalized π systems: one homoleptic complex [Ru II (dpbpy) 3 ](PF 6 ) 2 ( 1 ), and three heteroleptic complexes [Ru II (dpbpy) 2 (phen)](PF 6 ) 2 ( 2 ), [Ru II (dpbpy)(phen) 2 ](PF 6 ) 2 ( 3 ) and [Ru II (dpbpy) 2 (CN–Me)](PF 6 ) 2 ( 4 ). All of them contain 4,4′-diphenyl-2,2′-bipyridine ( dpbpy ) and 1,10-phenantroline ( phen ) or N-methyl-N′-2-pyridilimidazolium (CN–Me) ligands. The complexes have been characterized by spectroscopic, structural and electrochemical methods. UV–vis absorption in solution show the red shift for the metal to ligand charge transfer (MLCT) transitions after changing phen by dpbpy and carbene ligands. The photoluminescence emission spectra of 1 – 4 supported by theoretical calculations using time-dependent density-functional theory (TDDFT) suggest that the lowest energy excited state is mainly 3 MLCT. Complex 2 exhibits the highest phosphorescence emission with a quantum yield (Φ P ) in CH 2 Cl 2 of 44.1 %, followed by complex 1 (Φ P = 40.0 %), whereas complex 4 shows the lowest quantum efficiency (Φ P = 16.0 %), what suggest that the introduction of the CN–Me carbene ligand produces a significant quenching of the phosphorescence. Phosphorescence triplet state lifetimes between 0.96 and 1.74 μs were shown for 1 – 4 in degassed CH 2 Cl 2 . All complexes are proven to be efficient singlet oxygen photosensitizers. The trend in the redox potentials becomes more positive by increasing the number of phen ligands in the complexes, in full agreement with the HOMO's energy level and the blue shift of the MLCT transitions in the absorption spectra. Complexes internalization was analysed in tumorigenic mammary epithelial SKBR-3 cells, being complexes 1 and 2 the most well internalized. The effect of the photodynamic treatment using light-activated complexes 1 and 2 for 10 min demonstrated to increase cell death, being the homoleptic complex 1 an outstanding candidate as potential theranostic agent for bioimaging and PDT.

Ruthenium terpyridine complexes based on dppz ligands as photodynamic antimicrobial agents against Staphylococcus aureus

Ruthenium polypyridine complexes with triphenylamine groups as antibacterial agents against Staphylococcus aureus with membrane-disruptive mechanism

Synthesis and antibacterial against S. aureus of new ruthenium (II) polypyridine complexes containing pyrene groups

AIE-based ruthenium complexes as photosensitizers for specifically photo-inactivate gram-positive bacteria

Cellular membrane-targeting ruthenium complexes as an efficient photosensitizer for broad-spectrum antibacterial activity

Polypyridyl ruthenium complexes with benzothiazole moiety as membrane disruptors and anti-resistance agents for Staphylococcus aureus

Lysosome Targeting Bis-terpyridine Ruthenium(II) Complexes: Photophysical Properties and in Vitro Photodynamic Therapy.

Polymeric ruthenium precursor as a photoactivated antimicrobial agent

Synthesis, DNA photocleavage, singlet oxygen photogeneration and two photon absorption properties of ruthenium-phenanthroline porphyrins

Ruthenium Complexes with Pyridazine Carboxylic Acid: Synthesis, Characterization, and Anti-Biofilm Activity

Phenanthrene Appending Ruthenium Complexes: DNA Binding, Molecular Docking, TDDFT Calculation, and Photocytoxicity In Vitro

Developing photo-activable ruthenium (II) complexes for PDT: Synthesis, characterization, photophysical and biological studies

Near-IR/Visible-Emitting Thiophenyl-Based Ru(II) Complexes: Efficient Photodynamic Therapy, Cellular Uptake, and DNA Binding.

Two Ru(II) compounds with aggregation induced emission as promising photosensitizers for photodynamic therapy

DNA Interaction, DNA Photocleavage, Photocytotoxicity In Vitro, and Molecular Docking of Naphthyl-Appended Ruthenium Complexes

A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent

Study on antitumor activity of three ruthenium arene complexes in vitro

Synthesis, DNA Binding Mode, Singlet Oxygen Photogeneration and DNA Photocleavage Activity of Ruthenium Compounds with Porphyrin-Imidazo[4,5-f ]phenanthroline Conjugated Ligand

Ru(II) Complexes with Absorption in the Photodynamic Therapy Window: 1 O 2 Sensitization, DNA Binding, and Plasmid DNA Photocleavage

Synthesis of Ruthenium-phenanthroline Porphyrins Interacting with DNA

8-Hydroxyquinoline-modified ruthenium(II) polypyridyl complexes for JMJD inhibition and photodynamic antitumor